A detailed history of Ewg Elevate Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Ewg Elevate Inc. holds 3,585 shares of ABBV stock, worth $610,704. This represents 0.31% of its overall portfolio holdings.

Number of Shares
3,585
Previous 3,579 0.17%
Holding current value
$610,704
Previous $613,000 15.33%
% of portfolio
0.31%
Previous 0.24%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$163.84 - $199.33 $983 - $1,195
6 Added 0.17%
3,585 $707,000
Q2 2024

Jul 15, 2024

SELL
$154.79 - $180.76 $7,739 - $9,038
-50 Reduced 1.38%
3,579 $613,000
Q1 2024

Apr 09, 2024

BUY
$159.82 - $182.1 $8,949 - $10,197
56 Added 1.57%
3,629 $660,000
Q4 2023

Jan 08, 2024

SELL
$137.6 - $154.97 $3,302 - $3,719
-24 Reduced 0.67%
3,573 $553,000
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $480,523 - $556,276
3,597 New
3,597 $536,000
Q4 2022

Jan 10, 2023

BUY
$138.31 - $165.87 $109,541 - $131,369
792 New
792 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ewg Elevate Inc. Portfolio

Follow Ewg Elevate Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ewg Elevate Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ewg Elevate Inc. with notifications on news.